Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Multitasking Immune Sp185/333 Protein, rSpTransformer-E1, and Its Recombinant Fragments Undergo Secondary Structural Transformation upon Binding Targets.

Lun CM, Bishop BM, Smith LC.

J Immunol. 2017 Apr 1;198(7):2957-2966. doi: 10.4049/jimmunol.1601795. Epub 2017 Feb 27.

PMID:
28242650
2.

Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo Dragon) by Large-Scale Analyses and De-Novo-Assisted Sequencing Using Electron-Transfer Dissociation Mass Spectrometry.

Bishop BM, Juba ML, Russo PS, Devine M, Barksdale SM, Scott S, Settlage R, Michalak P, Gupta K, Vliet K, Schnur JM, van Hoek ML.

J Proteome Res. 2017 Apr 7;16(4):1470-1482. doi: 10.1021/acs.jproteome.6b00857. Epub 2017 Feb 24.

PMID:
28164707
3.

Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.

Petite SE, Bishop BM, Mauro VF.

Am J Ther. 2016 Feb 23. [Epub ahead of print]

PMID:
26910057
4.

Endovascular Interventions for Acute Ischemic Stroke: A Review of Recent Trials.

Bishop BM.

Ann Pharmacother. 2016 Mar;50(3):219-28. doi: 10.1177/1060028015620199. Epub 2015 Dec 31. Review.

PMID:
26721644
5.

Pharmacotherapy Considerations in the Management of Transgender Patients: A Brief Review.

Bishop BM.

Pharmacotherapy. 2015 Dec;35(12):1130-9. doi: 10.1002/phar.1668. Review.

PMID:
26684553
6.

Large Scale Discovery and De Novo-Assisted Sequencing of Cationic Antimicrobial Peptides (CAMPs) by Microparticle Capture and Electron-Transfer Dissociation (ETD) Mass Spectrometry.

Juba ML, Russo PS, Devine M, Barksdale S, Rodriguez C, Vliet KA, Schnur JM, van Hoek ML, Bishop BM.

J Proteome Res. 2015 Oct 2;14(10):4282-95. doi: 10.1021/acs.jproteome.5b00447. Epub 2015 Sep 23.

PMID:
26327436
7.

Endovascular therapy for ischemic stroke.

Bishop BM.

N Engl J Med. 2015 Jun 11;372(24):2364. doi: 10.1056/NEJMc1504715#SA3. No abstract available.

PMID:
26061846
8.
9.

Involving pharmacy technicians and students in the emergency department to expand care provided by clinical pharmacists.

Bishop BM.

Am J Health Syst Pharm. 2015 Jun 15;72(12):993-4. doi: 10.2146/ajhp150054. No abstract available.

PMID:
26025987
10.

Coping with death in the patient care setting.

Bishop BM, Shumate L.

Am J Health Syst Pharm. 2015 Jun 1;72(11):918, 920. doi: 10.2146/ajhp140562. No abstract available.

PMID:
25987684
11.

Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.

Bishop BM, Juba ML, Devine MC, Barksdale SM, Rodriguez CA, Chung MC, Russo PS, Vliet KA, Schnur JM, van Hoek ML.

PLoS One. 2015 Feb 11;10(2):e0117394. doi: 10.1371/journal.pone.0117394. eCollection 2015.

12.

Helical cationic antimicrobial peptide length and its impact on membrane disruption.

Juba ML, Porter DK, Williams EH, Rodriguez CA, Barksdale SM, Bishop BM.

Biochim Biophys Acta. 2015 May;1848(5):1081-91. doi: 10.1016/j.bbamem.2015.01.007. Epub 2015 Feb 3.

13.

Potential and emerging treatment options for Ebola virus disease.

Bishop BM.

Ann Pharmacother. 2015 Feb;49(2):196-206. doi: 10.1177/1060028014561227. Epub 2014 Nov 20. Review.

PMID:
25414384
14.

Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Bishop BM.

Am J Health Syst Pharm. 2014 Nov 1;71(21):1839-44. doi: 10.2146/ajhp130777. Review.

PMID:
25320133
15.

Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit.

Bishop BM, Bon JJ, Trienski TL, Pasquale TR, Martin BR, File TM Jr.

Ann Pharmacother. 2014 May;48(5):577-83. doi: 10.1177/1060028014520957. Epub 2014 Feb 11.

PMID:
24519479
16.

Systematic review of CETP inhibitors for increasing high-density lipoprotein cholesterol: where do these agents stand in the approval process?

Bishop BM.

Am J Ther. 2015 Mar-Apr;22(2):147-58. doi: 10.1097/MJT.0b013e31828b8463. Review.

PMID:
23567794
17.

Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.

Bishop BM, Mauro VF, Khouri SJ.

Pharmacotherapy. 2012 Sep;32(9):838-55. doi: 10.1002/j.1875-9114.2012.01114.x. Epub 2012 Jul 17. Review.

PMID:
22806762
18.

Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37.

Dean SN, Bishop BM, van Hoek ML.

Front Microbiol. 2011 Jul 4;2:128. doi: 10.3389/fmicb.2011.00128. eCollection 2011.

19.

Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus.

Dean SN, Bishop BM, van Hoek ML.

BMC Microbiol. 2011 May 23;11:114. doi: 10.1186/1471-2180-11-114.

20.

Antimicrobial activity of the Naja atra cathelicidin and related small peptides.

de Latour FA, Amer LS, Papanstasiou EA, Bishop BM, van Hoek ML.

Biochem Biophys Res Commun. 2010 Jun 11;396(4):825-30. doi: 10.1016/j.bbrc.2010.04.158. Epub 2010 May 10.

PMID:
20438706

Supplemental Content

Loading ...
Support Center